Apnimed’s IPO dream comes true with upsized $192M IPO to fund sleep apnea pill launch July 31, 2026Posted inBiotechnology Apnimed has raised $192 million for its upsized IPO, with the proceeds earmarked to fund the launch of its sleep apnea pill. Post navigation Previous Post Spatiotemporal Multiomics Charts Cellular Dynamics of Liver MetastasisNext PostNovo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 fail
